Mark L. Jacobson

Chief Operating Officer

Mark L. Jacobson (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $5.7M of AXSM (35,378 sh × $161.88, as filed), executed Feb 26.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.8M

shares × price, as filed

Last traded

Sep 3

Filed Sep 3

Median ADV $188.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $22.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

AXSM

Axsome Therapeutics, Inc. AXSM · 0 buys · 7 sells 7 filings

Recent filings

AXSMSALE Axsome Therapeutics, Inc. View filing → $2.1M
10,000 sh × $208.65
Exec Sep 3
Filed Sep 3 · 7:09 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $1.0M
4,517 sh × $227.94
Exec May 4
Filed May 5 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $5.7M
35,378 sh × $161.88
Exec Feb 26
Filed Feb 27 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $1.2M
10,000 sh × $115.96
Exec Sep 22 2025
Filed Sep 22 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $5.2M
45,783 sh across 2 lots
Exec Sep 16 2025
Filed Sep 17 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $2.8M
25,000 sh × $110.44
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. View filing → $4.2M
40,673 sh across 2 lots
Exec May 27 2025
Filed May 28 2025 · 5:30 PM ET